Cumberland Pharmaceuticals (CPIX) Revenue (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Revenue of $9.1 million for Q1 2026, down 33.24% sequentially from $13.7 million in Q4 2025, and down 22.04% YoY from $11.7 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Revenue (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Revenue for 17 years, with the latest figure at $9.1 million in Q1 2026.
- Quarterly Revenue fell 22.04% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.9 million (up 2.08% YoY) and the FY2025 annual result came in at $44.5 million, up 17.57% from the prior year.
- Revenue slipped to $9.1 million in Q1 2026 per CPIX's latest filing, from $13.7 million in the prior quarter.
- Over five years, Revenue peaked at $13.7 million in Q4 2025 and troughed at $8.3 million in Q3 2025.
- A 5-year average of $10.2 million and a median of $10.1 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2026: Revenue soared 41.38% in 2022, then fell 22.04% in 2026.
- Over 5 years, Revenue stood at $9.1 million in 2022, then increased by 2.51% to $9.4 million in 2023, then rose by 11.57% to $10.4 million in 2024, then soared by 31.08% to $13.7 million in 2025, then tumbled by 33.24% to $9.1 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $9.1 million, $13.7 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 117.16 Mn | 113.29 Mn | - | 166,458.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 166,458.00 |
| Mar 31, 2026 | 9.13 Mn |
| Dec 31, 2025 | 13.68 Mn |
| Sep 30, 2025 | 8.29 Mn |
| Jun 30, 2025 | 10.84 Mn |
| Mar 31, 2025 | 11.71 Mn |
| Dec 31, 2024 | 10.44 Mn |
| Sep 30, 2024 | 9.09 Mn |
| Jun 30, 2024 | 9.85 Mn |
| Mar 31, 2024 | 8.50 Mn |
| Dec 31, 2023 | 9.35 Mn |
| Sep 30, 2023 | 10.09 Mn |
| Jun 30, 2023 | 10.89 Mn |
| Mar 31, 2023 | 9.22 Mn |
| Dec 31, 2022 | 9.12 Mn |
| Sep 30, 2022 | 11.41 Mn |
| Jun 30, 2022 | 10.30 Mn |
| Mar 31, 2022 | 11.18 Mn |
| Dec 31, 2021 | 8.32 Mn |
| Sep 30, 2021 | 8.07 Mn |